Celgene completes purchase of Former Merck Property

- Celgene Corporation has completed its purchase of the former Merck & Co., Inc. property located at 556 Morris Ave. The property features 850,000 square feet of administrative office space, and 450,000 square feet of Research & Development space.

The acquisiton by Summit-headquartered Celgene, an integrated, global pharmaceutical company, extends the company’s existing Hilltop City presence beyond its 86 Morris Ave. global headquarters location. 

Combined with the completion of construction of a new 550,000-squar- foot office building at its 86 Morris Ave. location, the purchase allows Celgene to concentrate its New Jersey operations at two campuses in close proximity in Summit.
 
“This acquisition marks an important milestone in our company’s growth in New Jersey and our long relationship as a proud resident of Summit,” said Bob Hugin, Chairman and CEO of Celgene,  “A vibrant biopharmaceutical sector benefits patients, the healthcare system, and our local communities. With this new site, and the soon to be completed new building at our headquarters location, we are building an even stronger presence in this great community.”

Read more here. 

Up Next:


Up Next

  • Celgene completes purchase of Former Merck Property
  • Sea plane makes landing in East River
  • Dog beaten, left in middle of Baltimore road
  • 35-pound tabby cat stars in wedding photos with newly adopted family in Washington, DC
  • Senoia chief responds to accusations of officer's rudeness from 'Walking Dead' fan
  • DFCS document outlines horrifying family massacre
  • Sheriff: Massive multi-county drug operation busted
  • 5 things to know about the total solar eclipse on Aug. 21
  • Three wanted after children's charity donation machine stolen
  • DC police: 2 teens from missing African robotics team spotted entering Canada